Pemetrexed plus Platinum Chemotherapy with or Without Immuno Responses of Bevacizumab plus Cisplatin for the Non-Squamous Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions Therapy in Non-Squamous NSCLC: Descriptive Safety Analysis

被引：0
|
作者：
Li, X.
Li, J.
机构：
[1] Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Med Oncol, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
bevacizumab; Cisplatin; malignant pleural effusion;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-041
引用
收藏
页码：S2084 / S2084
页数：1
相关论文
共 50 条
  • [1] Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion
    Kazuhiro Kitamura
    Kaoru Kubota
    Masahiro Ando
    Satoshi Takahashi
    Nobuhiko Nishijima
    Teppei Sugano
    Masaru Toyokawa
    Koji Miwa
    Seiji Kosaihira
    Rintaro Noro
    Yuji Minegishi
    Masahiro Seike
    Akinobu Yoshimura
    Akihiko Gemma
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 457 - 461
  • [2] Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion
    Kitamura, Kazuhiro
    Kubota, Kaoru
    Ando, Masahiro
    Takahashi, Satoshi
    Nishijima, Nobuhiko
    Sugano, Teppei
    Toyokawa, Masaru
    Miwa, Koji
    Kosaihira, Seiji
    Noro, Rintaro
    Minegishi, Yuji
    Seike, Masahiro
    Yoshimura, Akinobu
    Gemma, Akihiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 457 - 461
  • [3] Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancer
    Masago, Katsuhiro
    Fujimoto, Daichi
    Fujita, Shiro
    Hata, Akito
    Kaji, Reiko
    Ohtsuka, Kyoko
    Okuda, Chiyuki
    Takeshita, Jumpei
    Katakami, Nobuyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (02) : 415 - 419
  • [4] A phase II study of bevacizumab in non-squamous, non-small-cell lung cancer patients with malignant pleural effusion
    Wu Di
    Cong Yue
    Zhang Ziran
    Zhang Jie
    Nie Jun
    Dai Ling
    Hu Weiheng
    Chen Xiaoling
    Ma Xiangjuan
    Tian Guangming
    Han Jindi
    Han Sen
    Wang Yang
    Long Jieran
    Fang Jian
    FUTURE ONCOLOGY, 2022, 18 (06) : 669 - 677
  • [5] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Tian, Yaru
    Tian, Hairong
    Zhai, Xiaoyang
    Zhu, Hui
    Yu, Jinming
    FRONTIERS OF MEDICINE, 2022, 16 (04) : 610 - 617
  • [6] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Yaru Tian
    Hairong Tian
    Xiaoyang Zhai
    Hui Zhu
    Jinming Yu
    Frontiers of Medicine, 2022, 16 : 610 - 617
  • [7] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer:a retrospective analysis
    Yaru Tian
    Hairong Tian
    Xiaoyang Zhai
    Hui Zhu
    Jinming Yu
    Frontiers of Medicine, 2022, 16 (04) : 610 - 617
  • [8] The efficacy and safety of pemetrexed plus bevacizumab in previously treated patients with advanced non-squamous non-small cell lung cancer (ns-NSCLC)
    Ding, Lingyu
    Liu, Kejun
    Jiang, Zhelong
    Chen, Qi
    Zhou, Ningning
    Liang, Ying
    Gao, Hongfei
    Hong, Xiangchan
    Wu, Haiying
    TUMOR BIOLOGY, 2015, 36 (04) : 2491 - 2499
  • [9] Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer
    Belani, Chandra P.
    Yamamoto, Nobuyuki
    Bondarenko, Igor M.
    Poltoratskiy, Artem
    Novello, Silvia
    Tang, Jie
    Bycott, Paul
    Niethammer, Andreas G.
    Ingrosso, Antonella
    Kim, Sinil
    Scagliotti, Giorgio V.
    BMC CANCER, 2014, 14
  • [10] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Nakagawa, Hiroaki
    Tomii, Keisuke
    Okada, Asuka
    Yoshimura, Kenichi
    Hirabayashi, Masataka
    Hirai, Toyohiro
    ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
12345